# Incretin Regulation of Insulin Secretion in Monogenic Diabetes

> **NCT01795144** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 10 (actual)

## Conditions studied

- Monogenic Diabetes

## Interventions

- **DRUG:** GLP-1
- **DRUG:** Exendin 9-39

## Key facts

- **NCT ID:** NCT01795144
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795144, "Incretin Regulation of Insulin Secretion in Monogenic Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01795144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*